However, a Slightly Higher Percentage of Surveyed MCO Pharmacy Directors Selected Humira Over Enbrel As the Most Efficacious Rheumatoid Arthritis Therapy, According to Findings from Decision Resources ...
A long-awaited moment for consumers arrived last year when patent protection expired on the nation’s most prescribed medicine, AbbVie’s wildly successful — and costly — rheumatoid arthritis drug ...
Since its spin-off from Abbott Labs, AbbVie has delivered outstanding performance, surpassing both its parent company and the S&P 500, thanks to the success of Humira. In 2022, AbbVie became the ...
NEW YORK -- Abbott Laboratories said Wednesday its profit grew 28 percent in the fourth quarter as sales of its arthritis drug Humira climbed and the company gained on the sale of its spinal-products ...
Abbott Laboratories said Wednesday its profit grew 28 percent in the fourth quarter as sales of its arthritis drug Humira climbed and the company gained on the sale of its spinal-products business.
NEW YORK (AP) -- Drugmaker Abbott Laboratories says its profit grew 28 percent in the fourth quarter as sales of its arthritis drug Humira climbed and the company gained on the sale of its spine ...
Sales of Abbott Laboratories’ blockbuster drug Humira combined with double-digit growth of medical devices and nutritionals to push profit up 28 percent in the fourth quarter, even as its competitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback